
0:00
28:32
Dr. Sam Sanders, internist at Bellevue Hospital in NYC, takes us through a case-based review of metabolic dysfunction–associated steatotic liver disease (MASLD), an increasingly common condition. We cover updated terminology, risk stratification using FIB-4 scoring and FibroScans, indications for hepatology referral, and new management strategies to prevent fibrosis progression and cirrhosis.
Advertising Inquiries: https://redcircle.com/brands
Altri episodi di "Run the List"



Non perdere nemmeno un episodio di “Run the List”. Iscriviti all'app gratuita GetPodcast.








